Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2015-02-06
Original market date: See footnote 1
1955-12-31
Product name:
BUMINATE 5%
DIN:
00118311
Product Monograph/Veterinary Labelling:
Date:
2013-03-13
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BAXTER HEALTHCARE CORPORATION
One Baxter Parkway
Deerfield
Illinois
United States
60015
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
16:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05AA01 ALBUMIN
Active ingredient group (AIG) number:See footnote5
0131452001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| ALBUMIN (HUMAN) | 5 % |